WallStSmart
TECX

Tectonic Therapeutic, Inc.

NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY

$28.81
+3.61% today

Updated 2026-06-03

Market cap
$553.62M
P/E ratio
P/S ratio
EPS (TTM)
$-4.46
Dividend yield
52W range
$14 – $36
Volume
0.2M

Tectonic Therapeutic, Inc. (TECX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2016201720182019202020212022202320242025
Total assets$5.40M$7.02M$133.48M$200.51M$271.23M$32.88M$47.21M$39.40M$152.91M$261.04M
Cash & equivalents$5.36M$5.96M$126.30M$187.04M$259.68M$28.06M$35.97M$28.77M$141.24M$253.80M
Current assets$5.38M$6.31M$130.02M$195.70M$267.24M$28.62M$37.04M$30.88M$146.86M$257.36M
Total liabilities$979000.00$3.66M$11.29M$14.50M$16.89M$47.84M$92.86M$124.03M$12.13M$9.71M
Current liabilities$891000.00$2.63M$10.61M$14.02M$16.61M$4.12M$7.84M$40.89M$11.61M$9.67M
Long-term debt
Shareholder equity$4.42M$3.37M$122.18M$186.01M$254.34M$-14.96M$-45.65M$-84.64M$140.78M$251.33M
Retained earnings$-4.83M$-23.48M$-71.74M$-144.70M$-264.42M$-15.60M$-47.78M$-90.60M$-148.59M$-222.74M
Accounts receivable$1.54M$2.14M$2.56M$2.70M$269000.00
Inventory
Goodwill

Frequently asked questions

How much free cash flow does TECX generate?

TECX produced $-60.29M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is TECX's balance sheet healthy?

TECX holds $253.80M in cash and equivalents against — in long-term debt, on $251.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.